ArticleClinicoEconomics and outcomes research : CEOR2022

Cost-Effectiveness Analysis of the Oncotype DX Breast Recurrence Score

Vladislav Berdunov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.